Sold to a pharmaceutical company…
The bankrupt 23andMe, along with all of its genetic data, has been bought by US drugmaker Regeneron Pharmaceuticals.
www.malwarebytes.com
23andMe and its customers’ genetic data bought by a pharmaceutical org
Posted: May 20, 2025 by
Pieter Arntz
The
bankrupt genetic testing company 23andMe has been scooped up by drug producer Regeneron Pharmaceuticals for $256 million dollars.
But why would a pharmaceutical company like Regeneron buy a bankrupt genetics testing company like 23andMe for such a large amount of money?
Well, Regeneron is a leading biotechnology company that invents, develops, and monetizes life-transforming medicines for people with serious diseases. So, it seems obvious that Regeneron’s primary interest lies in the genetic data collected by 23andMe, and the situation raises complex ethical, privacy, and security concerns that customers should understand and address.
Regeneron has pledged to uphold data privacy and security, working closely with a court-appointed Customer Privacy Ombudsman, acknowledging the importance of customer data protection and the ethical use of genetic information.
Dr. George Yancopoulos, Regeneron’s president, said in a statement:
“We believe we can help 23andMe deliver and build upon its mission to help people learn about their own DNA and how to improve their personal health, while furthering Regeneron’s efforts to improve the health and wellness of many.”
However, the scenario is less grim than the fears uttered by Senator Cassidy, chair of the US Senate Health, Education, Labor, and Pensions Committee, who
expressed concerns about foreign adversaries, including the Chinese Communist Party, acquiring the sensitive genetic data of millions of Americans through 23andMe.
Regeneron already manages genetic data from
nearly three million people, so 23andMe’s 15 million customers significantly expand this resource. Besides the genetic data itself, Regeneron likely values the consumer genetics business infrastructure and research services that 23andMe built, which can complement Regeneron’s pharmaceutical pipeline and personalized medicine efforts.
Genetic data is uniquely sensitive because it contains deeply personal information about an individual’s health risks, ancestry, and even family relationships. Unlike traditional medical records protected under HIPAA, 23andMe’s genetic data is covered primarily by consumer privacy laws, which offer weaker protections.
What can consumers do to protect their data?
Customers should actively manage their data on 23andMe by reviewing policies, deleting data if desired, and staying vigilant about how their sensitive genetic information is used.
People that have submitted samples to 23andMe have three different options, each providing a different level of privacy.
1. Delete your genetic data from 23andMe
For 23andMe customers who want to delete their data from 23andMe:
- Log into your account and navigate to Settings.
- Under Settings, scroll to the section titled 23andMe data. Select View.
- You will be asked to enter your date of birth for extra security.
- In the next section, you’ll be asked which, if there is any, personal data you’d like to download from the company (make sure you’re using a personal, not public, computer). Once you’re finished, scroll to the bottom and select Permanently delete data.
- You should then receive an email from 23andMe detailing its account deletion policy and requesting that you confirm your request. Once you confirm you’d like your data to be deleted, the deletion will begin automatically, and you’ll immediately lose access to your account.
2. Destroy your 23andMe test sample
If you previously opted to have your saliva sample and DNA stored by 23andMe, but want to change that preference, you can do so from your account settings page, under “Preferences.”
3. Revoke permission for your genetic data to be used for research
If you previously consented to 23andMe and third-party researchers using your genetic data and sample for research, you may withdraw consent from the account settings page, under
Research and Product Consents.
Check if you were caught up in the 23AndMe data breach
Additionally, you may want to
check if your data was exposed in the 2023 data breach. We recommend that you run a scan using our
free Digital Footprint Portal to see if your data was exposed in the breach, and then to take additional steps to protect yourself (we’ll walk you through those).
